Search

Your search keyword '"T Nikitina"' showing total 129 results

Search Constraints

Start Over You searched for: Author "T Nikitina" Remove constraint Author: "T Nikitina"
129 results on '"T Nikitina"'

Search Results

1. Neurohumoral gate for the entry of coronavirus into the central nervous system through the cribriform plate of the skull

2. P1724: QUALITY OF LIFE AND UNMET NEEDS AMONG PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASM PATIENTS: RESULTS OF THE NATIONWIDE SURVEY

3. PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING

4. PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY

5. Дослідження можливостей експлуатації швидкісних пасажирських поїздів за системою багатьох одиниць на залізниці україни

6. Amygdala: Neuroanatomical and Morphophysiological Features in Terms of Neurological and Neurodegenerative Diseases

13. P-546 The structure of genome variations at CNV level differs in recurrent and sporadic pregnancy loss

14. P-547 Confined placental mosaicism for inherited segmental aneuploidies in miscarriages traces early karyotype self-correction events

15. COURT SETTLEMENT AND OUT-OF-COURT SETTLEMENT OF DISPUTES, ARISING FROM THE RELATIONS OF HARM BY MEDICAL SPECIALIST

16. Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases

18. Research on opportunities of operation of speed passenger trains by the couple unit system on the railway of ukraine

19. BRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN A REAL WORLD SETTING: CLINICAL OUTCOMES AND IMPACT ON QUALITY OF LIFE

21. Multiobjective Parametric Synthesis of Robust Control by Rolling Mills Main Electric Drives

22. Amygdala: Neuroanatomical and Morphophysiological Features in Terms of Neurological and Neurodegenerative Diseases

23. GeantV: Results from the prototype of concurrent vector particle transport simulation in HEP

24. Competences for strengthening entrepreneurial capabilities in Europe

27. POS1324 TREATMENT OF UVEITIS ASSOCIATED WITH JUVENILE IDIOPATHIC ARTHRITIS: A SEVEN YEARS’ SINGLE-CENTRE EXPERIENCE

28. Analysis of Materials of the Federal State Educational Standards of Higher Education in the Context of Formation of Professional Communicative Competence of Cadets of Educational Organizations of Higher Education of the Federal Service for the Execution of Sanctions of Russia

29. Nationalism: theoretical approaches

31. AB0748 ARE ANY DIFFERENCES BETWEEN JIA - ASSOCIATED UVEITIS, DEVELOPED BEFORE AND AFTER JOINT MANIFESTATION

33. Experimental Research of Effectiveness of Active Shielding System of Overhead Transmission Lines Magnetic Field with Various Control Algorithms

34. PS1239 NIVOLUMAB FOR TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN'S LYMPHOMA (CHL): CLINICAL AND PATIENT-REPORTED OUTCOMES

36. PB1934 QUALITY OF LIFE IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE AFTER STOPPING TREATMENT BY TYROSINE KINASE INHIBITORS AT LONG-TERM FOLLOW-UP

37. High voltage power line magnetic field reduction by active shielding means with single compensating coil

38. GeantV: from CPU to accelerators

39. Stochastic optimization of GeantV code by use of genetic algorithms

40. Electromagnetic Physics Models for Parallel Computing Architectures

41. Recent developments in Geant4

42. Influence of antitumor drugs on free radical concentration in fungal cells during primary and secondary tumor-like growth

43. Towards a high performance geometry library for particle-detector simulations

44. The GeantV project: preparing the future of simulation

45. Verification of Electromagnetic Physics Models for Parallel Computing Architectures in the GeantV Project

46. Performance of GeantV EM Physics Models

47. Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for the upfront therapy of transplant ineligible patients with multiple myeloma

48. GeantV: from CPU to accelerators

50. [Influence of antitumor preparations on the concentration of free radicals in cells of Fusarium bulbigenum var. blasticola fungus during primary and tumour-like secondary growth]

Catalog

Books, media, physical & digital resources